Work

Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial

FWCI: 6.229
Cites: 15
Cited by: 215
Related to: 10